Limited Competition: Research Centers in Minority Institutions (RCMI) Clinical Research Network for Health Equity (UG3/UH3 - Clinical Trial Optional)

This Funding Opportunity Announcement (FOA) invites applications from current Research Centers in Minority Institutions (RCMI) awardees to participate in the RCMI Clinical Research Network for Health Equity (RCMI-CRNHE), a newly established clinical research network that will transform the development, delivery, and sustainability of evidence-based health care practices and services by providing the infrastructure to leverage community-based clinicians and/or health care delivery systems to conduct research addressing health care for populations that experience health disparities including the diverse clinicians providing health services. The UG3/UH3 Cooperative Agreement involves 2 phases. The UG3 phase, for up to 2 years, is designed to support a project with specific milestones to be accomplished by the end of the period. The UH3 phase is to provide funding for up to 3 additional years following successful completion of the UG3. UG3 projects that meet their milestones will be administratively considered by NIMHD and prioritized for transition to the UH3 phase. Investigators submitting to this FOA must describe both UG3 and UH3 phases.
Categories: Health.